IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MERONI, PIERLUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.011
NA - Nord America 19.032
AS - Asia 16.719
SA - Sud America 1.913
AF - Africa 329
OC - Oceania 83
Continente sconosciuto - Info sul continente non disponibili 15
Totale 60.102
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.356
GB - Regno Unito 8.203
CN - Cina 5.972
SG - Singapore 4.786
IT - Italia 3.092
DE - Germania 2.253
RU - Federazione Russa 1.993
SE - Svezia 1.857
HK - Hong Kong 1.614
BR - Brasile 1.301
TR - Turchia 1.001
IE - Irlanda 818
IN - India 796
KR - Corea 775
FR - Francia 773
UA - Ucraina 726
NL - Olanda 722
VN - Vietnam 615
FI - Finlandia 553
CA - Canada 459
EU - Europa 412
JP - Giappone 262
ID - Indonesia 261
CO - Colombia 244
ES - Italia 177
PL - Polonia 172
MX - Messico 147
AR - Argentina 143
GR - Grecia 109
BD - Bangladesh 96
BE - Belgio 92
DK - Danimarca 91
CI - Costa d'Avorio 86
AT - Austria 70
IQ - Iraq 68
AU - Australia 66
CH - Svizzera 59
ZA - Sudafrica 54
CL - Cile 53
IR - Iran 51
EC - Ecuador 50
UZ - Uzbekistan 48
SA - Arabia Saudita 47
TW - Taiwan 46
PH - Filippine 43
RO - Romania 36
VE - Venezuela 34
EG - Egitto 33
PK - Pakistan 33
MA - Marocco 32
MY - Malesia 29
PE - Perù 29
PT - Portogallo 29
TH - Thailandia 25
KE - Kenya 22
UY - Uruguay 21
BO - Bolivia 20
IL - Israele 20
DZ - Algeria 19
RS - Serbia 18
LT - Lituania 17
NO - Norvegia 17
TN - Tunisia 17
HR - Croazia 16
HU - Ungheria 16
NZ - Nuova Zelanda 16
AE - Emirati Arabi Uniti 15
BG - Bulgaria 15
BY - Bielorussia 15
CZ - Repubblica Ceca 15
PY - Paraguay 15
KZ - Kazakistan 11
NP - Nepal 11
OM - Oman 11
CR - Costa Rica 10
JO - Giordania 10
LU - Lussemburgo 10
AL - Albania 9
AZ - Azerbaigian 9
DO - Repubblica Dominicana 9
ET - Etiopia 9
JM - Giamaica 9
GE - Georgia 8
LB - Libano 8
NG - Nigeria 8
SK - Slovacchia (Repubblica Slovacca) 8
TT - Trinidad e Tobago 8
HN - Honduras 7
KG - Kirghizistan 7
UG - Uganda 7
EE - Estonia 6
PS - Palestinian Territory 6
A2 - ???statistics.table.value.countryCode.A2??? 5
MD - Moldavia 5
SC - Seychelles 5
SI - Slovenia 5
AM - Armenia 4
BB - Barbados 4
CU - Cuba 4
LK - Sri Lanka 4
Totale 60.403
Salva come PNG Salva come JPEG
Città #
Southend 7.635
Singapore 2.514
Chandler 1.753
Hong Kong 1.542
Seattle 1.429
Ashburn 1.370
Beijing 1.256
Princeton 1.088
Milan 998
Wilmington 851
Dublin 804
Dallas 761
Council Bluffs 661
Ann Arbor 520
Redmond 518
Fairfield 473
Jacksonville 462
Hangzhou 451
Santa Clara 444
Mountain View 426
Bengaluru 425
Nanjing 421
Des Moines 396
Los Angeles 370
Dearborn 366
Hanover 348
Sakarya 341
Toronto 312
Frankfurt am Main 303
Woodbridge 303
Buffalo 296
Moscow 272
Houston 268
Guangzhou 238
Boardman 236
Shanghai 226
Serra 215
Redwood City 202
Bogotá 199
Somerville 195
Andover 191
Columbus 178
The Dalles 178
New York 173
Hefei 172
Cangzhou 166
Sunnyvale 165
Grafing 164
Dong Ket 160
Jinan 160
Cambridge 150
Shenyang 147
Phoenix 146
Tokyo 136
Jakarta 120
São Paulo 118
Hebei 114
Tianjin 113
Eitensheim 106
Ho Chi Minh City 105
Munich 105
Changsha 104
Nanchang 101
Warsaw 101
Berlin 87
Rome 87
Helsinki 86
Abidjan 84
Athens 84
Zhengzhou 84
Hanoi 83
Jiaxing 76
Pisa 76
Brussels 67
Fuzhou 66
San Diego 66
Chicago 58
Shenzhen 58
Hamburg 56
London 54
Istanbul 53
Bitonto 52
Seoul 51
Ottawa 49
Madrid 48
Falls Church 47
Kunming 47
Wuhan 44
Nuremberg 43
Tashkent 38
Fremont 36
Mumbai 35
Taizhou 35
Haikou 34
Norwalk 34
Curitiba 33
Redondo Beach 33
Washington 32
Florence 31
Turin 31
Totale 37.239
Salva come PNG Salva come JPEG
Nome #
Management of Thrombotic Antiphospholipid Syndrome 748
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study 629
The X chromosome and the sex ratio of autoimmunity 557
The role of environmental estrogens and autoimmunity 550
Complement activation in anti-phospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery 460
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) 443
Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases 382
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 345
Inflammatory response and the endothelium 318
Antiphospholipid Antibodies and Infertility : A Gene Expression Study in Decidual Stromal Cells 307
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis 306
X chromosome monosomy : a common mechanism for autoimmune diseases 302
Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome 290
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation 289
Cerebrospinal fluid phosphorylated neurofilament heavy chain and chitotriosidase in primary lateral sclerosis 285
Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis : "Pros" and "Cons" 278
Pidotimod : a reappraisal 274
mTOR as a multifunctional therapeutic target in HIV infection 273
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade 263
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 261
Anti-beta 2 glycoprotein I antibodies in centenarians 252
L’aumento del drive simpatico che si osserva durante bypass aortocoronarico correla con l’espressione delle citochine proinfiammatorie ed é attenuato dalla terapia betabloccante 251
X monosomy in female systemic lupus erythematosus 249
Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1 : prevalence in systemic lupus erythematosus 248
Circulating stem cell factor in patients with chronic idiopathic urticaria 243
Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome : evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients 242
Complement activation and endothelial perturbation parallel COVID-19 severity and activity 240
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers 237
Prolactin's role in the pathogenesis of the antiphospholipid syndrome 232
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis 228
Treatment of Thrombotic Antiphospholipid Syndrome : The Rationale of Current Management - An Insight into Future Approaches 227
Anti-inflammatory and immunosuppressive drugs and reproduction 218
Primary biliary cirrhosis and Sjögren's syndrome : autoimmune epithelitis 216
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 213
Complement activation in patients with COVID-19: a novel therapeutic target 209
Protective effect of a synthetic peptide mimicking the b2GPI PL-binding site on aPL-induced placental damage 207
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers 207
Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment : relationships with endothelial function, coagulation and inflammation 204
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus 203
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis : A EUSTAR analysis 196
IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus 193
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide 191
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 191
Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects 190
TLR-4 and Annexin A2 Involvement in endothelial cell activation by anti-phospholipid antibodies : specific silencing by small interfering RNAs 190
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis : the interferon-inducible gene IFI16 189
The geoepidemiology of autoimmune liver disease 186
Up-date on the antiphospholipid syndrome 185
The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies 184
The chemokine scavenger receptor D6 protects the fetus from inflammation-induced abortion 183
Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 183
Association between clinical features and inflammatory gene SNPs in APS 182
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients 181
Patients with antiphospholipid syndrome display endothelial perturbation 179
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 179
L’evoluzione da sindrome da anticorpi antifosfolipidi primaria a lupus eritematoso sistemico : possono gli anticorpi anti-nucleosomi essere predittivi? 178
Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss 178
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis 176
Anti-phospholipid induced murine fetal loss : novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss 176
Antiphospholipid antibodies and the antiphospholipid syndrome : pathogenic mechanisms 174
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs : an Italian multicentre study 173
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 171
Measuring IgA anti-β2-glycoprotein I and IgG/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome 171
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor 170
Anti-phospholipid antibody mediated fetal loss : still an open question from a pathogenic point of view 170
Endothelium as a target for antiphospholipid antibodies 169
ANA screening : an old test with new recommendations 169
Mechanisms of action of antiphospholipid antibodies 168
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 167
Systemic Lupus erythematosus complicated by thrombotic thrombocytopenic purpura 167
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases--a multicentre prospective study 166
Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis : report of a family with multiple anti-phospholipid positive members 166
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays : an Italian multicentre study 164
T cell defect in essential mixed cryoglobulinaemia 164
Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers 163
Antiphospholipid antibodies and ex-vivo endothelial perturbation 163
The role of superoxide anion generation in antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity 163
Rheumatoid arthritis : a female challenge 162
The detection of lupus anticoagulants in hemophiliacs : the need for different assay systems 160
Assessment of musculoskeletal hand involvement in systemic sclerosis using ultrasonography and plain radiography 160
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in Chronic Fatigue Syndrome and Fibromyalgia but not in Depression: Preliminary report 159
Statins and autoimmune diseases 159
Autoimmunity and anti-TNF-alpha agents 159
Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study 159
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2-glycoprotein i domain 1 and domain 4/5 : ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome 158
Antiphospholipid syndrome and systemic lupus erythematosus patients: what's new about cognitive involvement? 157
Anti-DNA antibodies : a diagnostic and prognostic tool for systemic lupus erythematosus? 157
Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases 157
Juvenile idiopathic arthritis in adulthood : evaluation of disease activity, damage and quality of life 157
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study 156
Toll-like receptors : another player in the pathogenesis of the anti-phospholipid sindrome 156
Anti-NR2 antibodies and primary antiphospholipid syndrome : a preliminary study 156
The long-term prognosis of renal transplantation in patients with lupus nephritis 155
Hand impairment in systemic sclerosis : association of different hand indices with organ involvement 155
The Efficacy of Treatment with Low Dose Aspirin and Low Molecular Weight Heparin in Pregnant Women with Criteria Anti-Phospholipid Antibodies 153
Prevalence of autoantibodies against structure specific recognition protein 1 in systemic lupus erythematosus 152
Counseling on family planning and contraception in patients with rheumatic diseases : Analysis of 324 patient-reported questionnaires from a multicenter Italian study 152
Anti-beta-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. 151
Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicenter retrospective follow-up study 151
The role of ultrasonography in the assessment of skeletal hand involvement in systemic sclerosis 151
Totale 22.186
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.797
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.633 0 0 0 0 0 458 259 292 627 271 1.320 406
2021/20224.662 396 177 123 194 323 256 456 288 539 478 397 1.035
2022/20236.277 881 586 530 773 637 1.323 112 423 576 73 251 112
2023/20243.665 118 314 204 238 968 267 99 177 79 215 445 541
2024/20259.442 402 1.099 228 856 775 391 339 1.066 533 756 907 2.090
2025/20269.114 1.773 1.026 2.400 1.578 2.152 185 0 0 0 0 0 0
Totale 63.911